Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in

Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands

Oct 2020

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

2020 IMPACT

Cough and cold products benefit from consumer concerns about COVID-19 and associated symptoms

Cough, cold and allergy (hay fever) remedies saw quite strong growth in Q1 of 2020. This is due to categories most relevant to COVID-19 symptoms benefitting from the pandemic.

Allergy products see Q1 spike, but consumers over-stockpiled as lockdowns meant a milder allergy season and lesser need for such medicines

As seen with cough and cold products, allergy products also saw a spike in Q1 as consumers were worried about supply before the upcoming allergy season in spring and summer 2020, when hay fever (and other allergies) are rife. Consumers were seen to stockpile allergy products during that period, as they did not want to run out of allergy medicines and thus appear sick in public, in case it was assumed they were ill with COVID-19.

Innovations in fast-acting, convenient and non-drowsy products lead competitive developments

The powerhouse of GSK Consumer Healthcare took the lead in cough, cold and allergy remedies in 2020, winning shares from previous leader Lofthouse of Fleetwood Ltd (with its Fisherman’s Friend brand). This is thanks to the ongoing success of GSK Consumer Healthcare’s Otrivin brand and its backing from global owner GlaxoSmithKline Plc.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Cough, Cold and Allergy Sample Report Cough, Cold and Allergy Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Netherlands with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Netherlands, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in Netherlands market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Netherlands?
What are the major brands in Netherlands?
What is the impact of influenza vaccinations on the sales of cough and cold products?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Cough and cold products benefit from consumer concerns about COVID-19 and associated symptoms

Allergy products see Q1 spike, but consumers over-stockpiled as lockdowns meant a milder allergy season and lesser need for such medicines

Innovations in fast-acting, convenient and non-drowsy products lead competitive developments

RECOVERY AND OPPORTUNITIES

Ongoing innovations and educational narratives give players a competitive advantage

Awareness of oak processionary moths grows, as allergic reactions to the caterpillar hairs are similar to COVID-19 symptoms

Private label players to gain a competitive advantage by emulating developments with more affordable products

CATEGORY DATA

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025

Consumer Health in the Netherlands - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 8 Life Expectancy at Birth 2015-2020

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2015-2020
Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2015-2020
Table 14 Distribution of Consumer Health by Format: % Value 2015-2020
Table 15 Distribution of Consumer Health by Format and Category: % Value 2020
Table 16 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

Megatrends

Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands

New Report Guarantee

Executive Summary

New Report Guarantee

2020 IMPACT

Cough and cold products benefit from consumer concerns about COVID-19 and associated symptoms

Allergy products see Q1 spike, but consumers over-stockpiled as lockdowns meant a milder allergy season and lesser need for such medicines

Innovations in fast-acting, convenient and non-drowsy products lead competitive developments

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Cough and cold products benefit from consumer concerns about COVID-19 and associated symptoms

Allergy products see Q1 spike, but consumers over-stockpiled as lockdowns meant a milder allergy season and lesser need for such medicines

Innovations in fast-acting, convenient and non-drowsy products lead competitive developments

RECOVERY AND OPPORTUNITIES

Ongoing innovations and educational narratives give players a competitive advantage

Awareness of oak processionary moths grows, as allergic reactions to the caterpillar hairs are similar to COVID-19 symptoms

Private label players to gain a competitive advantage by emulating developments with more affordable products

CATEGORY DATA

Consumer Health in the Netherlands - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports